JOHNSON INVESTMENT COUNSEL INC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 821197
Cincinnati, OH
Position in REGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$291,816
-$77,505 QoQ
Shares Held
468
-2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#282
of 454 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $10,648,095 across 9 Biotechnology names. REGN ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,360 | $3,655,932 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
37,016 | $2,897,242 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
9,802 | $2,361,987 | |
| 4 | INCY |
Incyte Corp
|
4,681 | $530,638 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
8,212 | $451,167 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,000 | $326,040 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
468 | $291,816 | |
| 8 | AVIR |
Atea Pharmaceuticals, Inc.
|
25,590 | $118,993 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $291,816 | 468 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $369,321 | 478 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $357,375 | 463 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $260,331 | 463 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $243,075 | 463 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $308,235 | 486 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $346,904 | 487 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $294,347 | 280 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $236,481 | 225 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $216,560 | 225 | Shares | Sole | 2024-05-09 | |
| 2023-09-30 | $279,806 | 340 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $776,023 | 1,080 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $895,620 | 1,090 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $775,601 | 1,075 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $806,666 | 1,171 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $678,026 | 1,147 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $745,912 | 1,068 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $644,781 | 1,021 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $620,914 | 1,026 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $562,449 | 1,007 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $474,559 | 1,003 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $470,066 | 973 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $542,986 | 970 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $604,940 | 970 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $595,713 | 1,220 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||